People | April 10, 2026
Aniruddha Rajurkar appointed as CEO of Zenex Animal Health
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
The new capital is expected to fund the company through 2029
The center combines rigorous scientific instruction with practical, hands-on training, equipping providers with the clinical, consultative, and business skills needed to deliver safe, effective, and patient-centered care
The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
Board approves five-year appointment, subject to shareholder nod through postal ballot
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Subscribe To Our Newsletter & Stay Updated
